| 000 | 01509 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513074430.0 | ||
| 264 | 0 | _c19931018 | |
| 008 | 199310s 0 0 eng d | ||
| 022 | _a0741-5214 | ||
| 024 | 7 |
_a10.1067/mva.1993.48123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdwards, W H | |
| 245 | 0 | 0 |
_aCefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors. _h[electronic resource] |
| 260 |
_bJournal of vascular surgery _cSep 1993 |
||
| 300 |
_a470-5; discussion 475-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCefamandole _xtherapeutic use |
| 650 | 0 | 4 |
_aCefazolin _xtherapeutic use |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPremedication _xeconomics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aSurgical Wound Infection _xepidemiology |
| 650 | 0 | 4 |
_aVascular Surgical Procedures _xadverse effects |
| 700 | 1 | _aKaiser, A B | |
| 700 | 1 | _aTapper, S | |
| 700 | 1 | _aEdwards, W H | |
| 700 | 1 | _aMartin, R S | |
| 700 | 1 | _aMulherin, J L | |
| 700 | 1 | _aJenkins, J M | |
| 700 | 1 | _aRoach, A C | |
| 773 | 0 |
_tJournal of vascular surgery _gvol. 18 _gno. 3 _gp. 470-5; discussion 475-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mva.1993.48123 _zAvailable from publisher's website |
| 999 |
_c8376513 _d8376513 |
||